Clinical Guest Contributors
-
$25 Million Awards Help Cancer Researchers Make Clinical Trial Inroads
5/9/2024
Cancer Grand Challenges — a global research initiative cofounded by Cancer Research U.K. and the National Cancer Institute in the U.S. — supports cancer research that aims to answer some of the field’s most dire questions and pertinent needs.
-
Meaningful Industry Change Means Balancing Tech And Human Touch
5/6/2024
Technology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.
-
Multidisciplinary Collaborations Fuel New Glioma Treatment Breakthroughs
5/6/2024
Servier's Susan Pandya, MD, vice president of clinical development, shares what can be achieved when scientists, patients, investigators, and advocacy groups collaborate to create an innovative trial design for a potential breakthrough therapy.
-
Unleashing The Power Of Investigator-Sponsored Research (ISR) And Investigator-Initiated Trials (IIT)
5/3/2024
Investigator-sponsored research (ISR) and investigator-initiated trials (IIT) are essential to expanding the drugs currently available or under investigation, either alone or in combination, to address unmet medical needs.
-
Early Exposure & Site Network Support Enable PI’s Enduring Interest In Research
4/30/2024
Seasoned Phase 1 principal investigator and site co-director Manish Sharma, MD, recounts his career thus far as a PI, offering insights into PI motivation, retention, and satisfaction.
-
Take-Home Microdosing Trial Studies Sub-Hallucinogenic For Depression
4/30/2024
MindBio Therapeutics CEO Justin Hanka details the company’s Phase 2a clinical trial investigating the use of a take-home microdosing regimen for depression.
-
What Can Digital Patient Twins Do For Clinical Research?
4/29/2024
Digital patient twins have the potential to vastly improve our current healthcare systems by offering personalized therapeutics, enhanced health monitoring, and streamlined pharmaceutical manufacturing, including clinical trials.
-
Assessing The 3Cs: Does Your Organization Have The Foundation For Clinical Trial Success?
4/25/2024
In part one of this series on exploring the importance of culture, communication, and collaboration, the authors discuss the makings of a strong company foundation and offer an assessment plan meant to reveal strengths and weaknesses in those three areas.
-
Fortifying The 3 Cs With Strategic Approaches And Tools
4/25/2024
In part two of this series, the authors continue the discussion by identifying specific tools and strategies that companies can use to improve communication and collaboration.
-
Validating A Better ALS Biomarker With Coya’s Fred Grossman
4/24/2024
Coya Therapeutics President and CMO Fred Grossman, DO, FAPA discusses a potential new biomarker for ALS — 4-HNE, an oxidative stress biomarker — and how it could be more effective than the current standard, NfL.